Child/Adolescent Anxiety Multimodal Treatment Study

Anxiety disorders are among the most common conditions affecting children and adolescents. These disorders impair school, social, and family functioning. When left untreated, they also put children at risk for major depression and substance abuse in late adolescence and adulthood. Effective treatments that alleviate symptoms and prevent long-term morbidity and mortality associated with childhood-onset anxiety disorders are needed.

This study examines Cognitive Behavioral Therapy and Pharmacotherapy (Sertraline/Zoloft), both combined and separate.

Enrollment for this study is currently closed.